PAGUE MENOS (PGMN3) Main Indicators
Basic Data - PGMN3
Company | PAGUE MENOS |
Corporate Name | EMPREENDIMENTOS PAGUE MENOS S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | Comércio de produtos farmacêuticos. perfumarias e afins. sem manipulação de fórmulas. |
Share | PGMN3 |
Quote Date | 11/19/2024 |
Share Type | ON |
Last Closing | R$ 3.27 |
Quotation Factor | 1 Share |
Financial Volume | R$ 3.17 M |
Last Statement | ITR - 09/30/2024 |
Sector | Saúde |
Subsector | Comércio e Distribuição |
Segment | Medicamentos e Outros Produtos |
Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
Updated 11/21/2024 |
Relative Prices - PGMN3
Price/Earnings | 11.85 |
Price/SBV | 0.71 |
Price/Net Sales | 0.16 |
Price/CFO | 5.46 |
Price/FCF | 7.54 |
Price/Total Assets | 0.22 |
Price/EBIT | 3.37 |
Price/Working Capital | 1.62 |
Price/NCAV | -0.40 |
EV/EBIT | 5.66 |
EV/EBITDA | 2.99 |
EV/Net Sales | 0.26 |
EV/CFO | 9.18 |
EV/FCF | 12.68 |
EV/Total Assets | 0.37 |
Company Market Cap | R$ 1.90 B |
Enterprise Value | R$ 3.20 B |
Current Financial Statement Date | 09/30/2024 |
Current Share Price | R$ 3.27 |
Share Price Date | 11/19/2024 |
Dividend Yield | 9.05% |
Updated 11/21/2024 |
Income Statement - PGMN3
Net Revenue | R$ 12.16 B |
Gross Result | R$ 3.85 B |
EBIT | R$ 564.46 M |
Depreciation and Amortization | - R$ 503.55 M |
EBITDA | R$ 1.07 B |
Net Profit | R$ 160.46 M |
Net Profit/Share | R$ 0.28 |
Updated 11/04/2024 |
Net Revenue | R$ 3.27 B |
Gross Result | R$ 1.03 B |
EBIT | R$ 173.24 M |
Depreciation and Amortization | - R$ 128.74 M |
EBITDA | R$ 301.98 M |
Net Profit | R$ 40.90 M |
Profit/Share | R$ 0.07 |
Updated 11/04/2024 |
Price and Volume Behavior - PGMN3
Lowest Price 52 weeks | R$ 2.20 |
Highest Price 52 weeks | R$ 3.62 |
Variation 2024 | -7.39% |
Variation 1 year | -2.33% |
Variation 2 years(total) | -19.05% |
Variation 2 years(yearly) | -10.00% |
Variation 3 years(total) | -57.15% |
Variation 3 years(yearly) | -24.59% |
Variation 4 years(total) | -55.30% |
Variation 4 years(yearly) | -18.23% |
Variation 5 years(total) | - |
Variation 5 years(yearly) | - |
Average Daily Volume (3 months) | R$ 2.12 M |
Updated 11/21/2024 |
Returns and Margins - PGMN3
Return on Initial Tangible Capital | 10.41% |
Return on Initial Invested Capital | 9.88% |
Pre-Tax Return on Initial Tangible Capital | 15.78% |
Pre-Tax Return on Initial Invested Capital | 14.96% |
Return on Initial Shareholder´s Equity | 6.27% |
Return on Initial Asset | 1.84% |
Gross Margin | 31.68% |
Net Margin | 1.32% |
EBIT Margin | 4.64% |
EBITDA Margin | 8.78% |
Initial Asset Turnover | 1.40 |
Financial Leverage | 3.24 |
Liabilities/Net Worth | 2.24 |
Net Debt/EBITDA | 1.21 |
Updated 11/04/2024 |
Balance Sheet - PGMN3
Cash and Cash Equivalents | R$ 169.60 M |
Total Assets | R$ 8.64 B |
Short-Term Debt | R$ 383.32 M |
Long-Term Debt | R$ 1.08 B |
Gross Debt | R$ 1.46 B |
Net Debt | R$ 1.30 B |
Shareholder´s Equity | R$ 2.66 B |
Share Book Value | R$ 4.58 |
Common Shares | 581,715,639 |
Preferred Shares | 0 |
Total | 581,715,639 |
Common Shares in Treasury | 6,856,609 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 6,856,609 |
Common Shares (Except Treasury) | 574,859,030 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 574,859,030 |
Updated 11/04/2024 |
Cash Flow - PGMN3
Operating Cash Flow | R$ 348.31 M |
Cash Flow from Investments | - R$ 292.45 M |
Financing Cash Flow | - R$ 411.76 M |
Increase (Reduction) in Cash and Equivalents | - R$ 355.90 M |
Updated 11/04/2024 |
Operating Cash Flow | R$ 169.11 M |
Cash Flow from Investments | - R$ 19.14 M |
Financing Cash Flow | - R$ 88.58 M |
Increase (Reduction) in Cash and Equivalents | R$ 61.39 M |
Updated 11/04/2024 |
Experimental - PGMN3
CAPEX 3 months | - R$ 16.94 M |
Free Cash Flow 3 months | R$ 152.16 M |
CAPEX 12 months | - R$ 96.10 M |
Free Cash Flow 12 months | R$ 252.21 M |
Updated 11/04/2024 |